LYZZ CAPITAL
LYZZ Capital is a venture capital firm that specializes in seed, early and expansion stage venture investments.
Business Model:
Revenue: $0
Employees: 0-0
Rankings
Industries / Tags:
Detailed LYZZ CAPITAL Information
Geographic Data
Address:
City:
State:
Zip:
Country:
Financial Info
Stage:
Raised Last:
$0
Raised Total:$0
Social
Linkedin
Crunchbase
Metrics
2,709,746Website Global Rank
6,432Website Monthly Traffic
Twitter Followers
Description
LYZZ Capital is a venture capital firm that specializes in seed, early and expansion stage venture investments.
Contact Phone:
Contact Email:
| Announced Date | Company | Transaction | Money Raised |
|---|---|---|---|
| 1/2017 | Neurelis | Series B | 42.1M |
| 6/2022 | Mojia Bioscience | Series B | 0 |
| 4/2015 | Chipscreen | Venture Round | 7.7M |
| 1/2021 | Jumpcode Genomics | Series B | 21M |
| 4/2020 | Mabworks | Series C | 0 |
| 12/2021 | Viron | Series B | 50M |
| 12/2021 | OncoMyx Therapeutics | Series B | 0 |
| 3/2021 | Neurelis | Series D | 0 |
| 4/2018 | NewMed Medical | Series A | - |
| 7/2020 | Onchilles Pharma | Series A | 7M |
| 7/2021 | Wugen | Series B | 0 |
| 2/2016 | Neurelis | Series A | - |
| 10/2018 | Qpex Biopharma | Series A | 33M |
| 4/2022 | SUSTAO | Series A | - |
| 12/2018 | WT Microtech Medical | Series C | - |
| 6/2018 | Alpha Biopharma | Series A | 37M |
| 6/2022 | Mojia Bioscience | Series B | 0 |
| 4/2022 | SUSTAO | Series A | - |
| 12/2021 | OncoMyx Therapeutics | Series B | 0 |
| 12/2021 | Viron Inc. | Series B | 0 |
| 7/2021 | Wugen | Series B | 0 |
| 3/2021 | Neurelis | Series D | 0 |
| 1/2021 | Jumpcode Genomics | Series B | 0 |
| 7/2020 | Onchilles Pharma | Series A | 0 |
| 4/2020 | Mabworks | Series C | 0 |
| 12/2018 | WT Microtech Medical | Series C | - |
Startup Industries
Startup Locations
Portfolio Current Status
Portfolio Employee Count
| Name | Price |
|---|
| Name | Size | Announced Date |
|---|
